Children's Autism Metabolome Project

NCT02548442 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1102

Last updated 2020-06-29

No results posted yet for this study

Summary

Development and Clinical Evaluation of the Stemina Metabolic Biomarker-Based Test to Diagnose Autism Spectrum Disorder in Early Childhood.

Conditions

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH
  • Nancy Lurie Marks Family Foundation

    collaborator OTHER
  • Stemina Biomarker Discovery, Inc.

    lead INDUSTRY

Principal Investigators

  • Robert E Burrier, Ph.D. · Stemina Biomarker Discovery

Eligibility

Min Age
18 Months
Max Age
48 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2023-01-31
Completion
2023-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02548442 on ClinicalTrials.gov